TABLE 1.

Demographics and clinical information.

	NMOSD	Control group	P
Eyes	21	22
Gender	21/0	22/0
Age, years	48.0 (12.85)	47.78 (11.63)	0.953
BMI	22.34 (2.41)	23.82 (2.68)
Duration	5.30 (4.50)	–	<0.001
BCVA	0.44 (0.42)	1.11 (0.16)	<0.001
AL	23.43 (1.14)	23.35 (1.13)	0.843
IOP	13.70 (3.51)	12.16 (2.70)	0.117
Frequency of ON
1 time	8(28.6%)
2 times	13(57.1%)

NMOSD, neuromyelitis optica spectrum disorders; BMI, body mass index; BCVA, best corrected visual acuity; AL, axial length; IOP, intra-ocular pressure; ON, optic neuritis.